Leo Lens Technology

Leo Lens Technology (LLT) is an emerging San Diego-based company focused on using its unique platform technology to commercialize a drug-eluting, comfort-enhancing contact lens to treat millions of patients worldwide. While eye drops have been around for over 40 years and remain the standard of care for over 90% of patients, they have only around a... 50% compliance rate. This leads millions to suffer from disease progression and thousands to suffer from preventable blindness. There is a large unmet need for a better non-invasive treatment option in this $10B US market. LLT's patented technology offers a unique value proposition for patients, practitioners, strategic partners, and payers. LLT is currently focused on getting its lead asset, a lens to treat glaucoma, to the clinic while continuing to build out its product pipeline. LLT had a successful pre-IND meeting with the FDA to confirm its regulatory strategy and will soon be submitting an IND for the glaucoma product.Read More